The Chosun Ilbo on MSN
GLP-1 obesity treatments linked to reduced addiction risks in major study
A study has found that GLP-1 class obesity treatments, such as Wegovy and Mounjaro, may reduce the risk of alcohol or drug ...
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...
Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...
My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results